Form D · Biotechnology
Serina Therapeutics, Inc.
Huntsville, AL · CIK 0001558525
Offering snapshot reported Mar 30, 2023 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 15, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 30, 2023 | Initial | $10,000,000 | No comparison | 1 | SEC filing |
| Nov 14, 2022 | Initial | $3,650,000 | No comparison | 1 | SEC filing |
| Jul 15, 2022 | Initial | $1,000,000 | No comparison | 3 | SEC filing |
| Jun 2, 2021 | Amendment | $3,681,009 | $0vs Jun 10, 2020 | 12 | SEC filing |
| Jun 10, 2020 | Amendment | $3,681,009 | $130,000vs Mar 4, 2020 | 12 | SEC filing |
| Mar 4, 2020 | Amendment | $3,551,009 | $3,451,009vs Jul 2, 2019 | 11 | SEC filing |
| Jul 2, 2019 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Apr 13, 2018 | Amendment | $8,220,966 | $1,284,465vs May 24, 2017 | 18 | SEC filing |
| Jan 22, 2018 | Amendment | $7,999,966 | $1,063,465vs May 24, 2017 | 16 | SEC filing |
| May 24, 2017 | Amendment | $6,936,501 | $2,880,601vs Feb 2, 2017 | 13 | SEC filing |
| Feb 2, 2017 | Initial | $4,055,900 | No comparison | 4 | SEC filing |
| Mar 18, 2015 | Amendment | $4,855,000 | No comparison | 21 | SEC filing |
| Mar 20, 2014 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 1, 2012 | Initial | $11,150,080 | No comparison | 36 | SEC filing |
| Sep 21, 2012 | Initial | $2,000,000 | No comparison | 5 | SEC filing |
| Sep 19, 2012 | Initial | $2,000,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-477378
Source: Form D, filed Mar 30, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Greg H Bailey, M.D. | Director |
| Michael D Bentley | Director, Executive |
| Barbara M Fisk | Director |
| J Milton Harris | Director, Executive |
| James R Hudson, Jr. | Director |
| Steve Ledger | Director |
| Miguel A Loya | Director |
| Lonnie S Mc Millian | Director |
| Randall W Moreadith | Director, Executive |
| Brendan Rae | Executive |
| Tacey Viegas | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
601 Genome Way Suite 2001
Huntsville, AL, 35806
Huntsville, AL, 35806